Under the leadership of Sanjay Srivatsan, PhD, the Srivatsan Lab at the Fred Hutchinson Cancer Center will focus on developing new sequencing technologies to understand how life’s various components assemble. This includes making biochemical measurements of designed proteins and inventing new single-cell co-assays to understand how designed proteins function in cellular contexts. This new lab is at the forefront of leveraging protein design and molecular sequencing to uncover the intricate dance between cells and the genes that guide their function.
Dr. Srivatsan’s groundbreaking work has refined single-cell RNA sequencing technologies, illuminating the genetic activity within individual cells and tissues. His innovations have traced the spatial positions of cells in tissues, creating ‘maps of development, and his journey will continue at the Hutch, pushing the boundaries of sequencing-based technologies.
